CYB003-001
Showing 1 - 25 of 3,080
MDD Trial in Eatontown (CYB003, Psychotherapy, Placebo)
Recruiting
- Major Depressive Disorder
- CYB003
- +2 more
-
Eatontown, New JerseyClinilabs Drug Development Corporation
Jul 11, 2022
Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Atlanta (VLP-encapsulated TLR9 Agonist CMP-001,,
Not yet recruiting
- Metastatic Prostate Adenocarcinoma
- Stage IV Prostate Cancer AJCC v8
- VLP-encapsulated TLR9 Agonist CMP-001,
- Nivolumab
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Aug 26, 2022
Locally Advanced Malignant Solid Tumor, Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in United
Recruiting
- Locally Advanced Malignant Solid Neoplasm
- +3 more
- Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949
- VLP-encapsulated TLR9 Agonist CMP-001
-
Scottsdale, Arizona
- +3 more
Jun 1, 2022
Warm Autoimmune Hemolytic Anemia (wAIHA) Trial in Worldwide (parsaclisinib, )
Recruiting
- Warm Autoimmune Hemolytic Anemia (wAIHA)
- parsaclisinib
- placebo
-
Los Angeles, California
- +52 more
Nov 15, 2022
ADHD Trial (FRx-001, FRx-003, FRx-004)
Not yet recruiting
- ADHD
- FRx-001
- +2 more
- (no location specified)
Jan 26, 2023
Digestive System Disease Trial in Anaheim (PvP001 , PvP001 100 mg, PvP001 300 mg)
Completed
- Digestive System Disease
- PvP001 placebo
- +11 more
-
Anaheim, CaliforniaAnaheim Clinical Trials
Feb 4, 2022
Coronary Stenosis Trial in France, Italy, Poland (BiOSS LIM C)
Terminated
- Coronary Stenosis
- BiOSS LIM C
-
Aix en Provence, France
- +14 more
Jul 25, 2022
Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)
Recruiting
- Mycobacterium Infections, Nontuberculous
- ALIS
- +3 more
-
Birmingham, Alabama
- +172 more
Jan 23, 2023
Pulmonary Arterial Hypertension Trial in Worldwide (Treprostinil Palmitil, Placebo)
Recruiting
- Pulmonary Arterial Hypertension
- Treprostinil Palmitil
- Placebo
-
West Hollywood, California
- +43 more
Jul 21, 2022
Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)
Active, not recruiting
- Mycobacterium Infections, Nontuberculous
- ALIS
- +3 more
-
Birmingham, Alabama
- +110 more
Jan 23, 2023
Non-Cystic Fibrosis Bronchiectasis Trial in Worldwide (Brensocatib 10 mg, Brensocatib 25 mg, Placebo)
Recruiting
- Non-Cystic Fibrosis Bronchiectasis
- Brensocatib 10 mg
- +2 more
-
Birmingham, Alabama
- +416 more
Jan 24, 2023
Articular Cartilage Disorder of Knee, Cartilage Damage, Microfractures Trial in United States (microfracture surgery + HST003)
Terminated
- Articular Cartilage Disorder of Knee
- +2 more
- microfracture surgery + HST003
-
Vail, Colorado
- +4 more
Jan 17, 2023
Parkinson Disease, Early Parkinson's Disease Trial in Worldwide (P2B001, Rasagiline, Pramipexole)
Active, not recruiting
- Parkinson Disease
- Early Parkinson's Disease
- P2B001
- +3 more
-
Scottsdale, Arizona
- +71 more
May 20, 2021
COVID-19 Trial in Worldwide (LY3819253, Placebo, Remdesivir)
Completed
- COVID-19
- LY3819253
- +2 more
-
Tucson, Arizona
- +56 more
Mar 22, 2023
Pulmonary Hypertension Trial in Worldwide (Treprostinil Palmitil, Placebo)
Recruiting
- Pulmonary Hypertension
- Treprostinil Palmitil
- Placebo
-
Los Angeles, California
- +17 more
Aug 2, 2022
Covid19 Trial in Brazil, United States (Remdesivir, Remdesivir Placebo, Aviptadil)
Completed
- Covid19
- Remdesivir
- +4 more
-
Tucson, Arizona
- +39 more
Dec 16, 2022
Vitrectomy Trial in United States (Vista Vitrectomy Probe)
Recruiting
- Vitrectomy
- Vista Vitrectomy Probe
-
Los Angeles, California
- +3 more
Jan 16, 2023
COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)
Completed
- COVID-19
- BRII-196
- +3 more
-
Tucson, Arizona
- +106 more
Mar 24, 2023
Age-related Wet Macular Degeneration Trial in United States (CG-P5 peptide, Placebo, Aflibercept Injection [Eylea])
Not yet recruiting
- Age-related Wet Macular Degeneration
- CG-P5 peptide
- +2 more
-
Augusta, Georgia
- +3 more
Nov 13, 2023
COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)
Completed
- COVID-19
- VIR-7831
- +2 more
-
Tucson, Arizona
- +104 more
Mar 22, 2023
Retinitis Pigmentosa, Retinitis Pigmentosa Syndrome Trial in United States (EA-2353)
Recruiting
- Retinitis Pigmentosa
- Retinitis Pigmentosa Syndrome
-
Miami, Florida
- +5 more
Jan 24, 2023